期刊文献+

间质性肺疾病急性加重患者的病原学检测

Analysis of the Results of Pathogenic Detection in Patients with Acute Exacerbation of Interstitial Lung Disease
下载PDF
导出
摘要 目的分析间质性肺疾病急性加重患者的病原学检测结果。方法选取2012-2016年收治的420例间质性肺疾病急性加重患者,对患者的病原学检查资料进行回顾性分析。结果 420例的病原学检查率大约为42.7%;235例曾经进行血清肺炎支原体抗体检测,其阳性率大约为24.7%;免疫抑制剂对痰培养影响,差异无统计学意义(P>0.05)。结论间质性肺疾病急性加重患者的主要病原体是肺炎支原体和巨细胞病毒。细菌感染主要是革兰阴性菌,但是真菌也相对常见。病原学的分布差异没有对患者肺功能和免疫抑制剂应用状况造成显著影响。 Objective To study the etiology of patients with acute exacerbation interstitial lung disease. Methods 420 cases of acute exacerbation interstitial lung disease in our hospital who accepted treatment during 2012 to 2016 were analyzed retrospectively. Results420 cases of etiological examination rate of about 42.7%, 235 cases had serum mycoplasma pneumoniae antibody detection, the positive rate of about 24.7%. Immunosuppressive agents had no statistically significant effect on sputum culture(P〉0.05). Conclusion Mycoplasma pneumoniae and cytomegalovirus are the major pathogens in patients with acute exacerbation interstitial lung disease. Gram negative bacteria are the main pathogens of bacterial infection, but fungi are relatively common. There is no significant effect on the distribution of pathogens in patients with pulmonary function and immunosuppressive agents.
作者 李梅
出处 《医疗装备》 2017年第15期57-58,共2页 Medical Equipment
关键词 间质性肺疾病 急性加重 病原学 检测 Interstitial lung disease Acute exacerbation Pathogen detection
  • 相关文献

参考文献4

二级参考文献30

  • 1郑劲平,康健,蔡柏蔷,周新,曹兆龙,白春学,钟南山.吸入噻托溴铵干粉与异丙托溴铵定量气雾剂治疗慢性阻塞性肺疾病的疗效与安全性比较[J].中华结核和呼吸杂志,2006,29(6):363-367. 被引量:158
  • 2曾勉,刘凌云,张式鸿,谢灿茂,王辉,黄晓梅.各期慢性阻塞性肺疾病患者诱导痰细胞成分与肺功能的关系[J].中山大学学报(医学科学版),2007,28(4):422-425. 被引量:26
  • 3张波.机械通气模式的发展与临床应用评价[J].中国实用内科杂志,2007,27(5):326-328. 被引量:17
  • 4Rider LG,Miller FW.Deciphering the clinical presentations,pathogenesis,and treatment of the idiopathic inflammatory myopathies myositis.JAMA,2011,305:183-190.
  • 5Hirakata M.Autoantibodies to aminoacyl-tRNA synthetases.Intern Med,2005,44:527-528.
  • 6Yoshifuji H,Fujii T,Kobayashi S,et al.Anti-aminoacyl-tRNA synthetase antibodies i(n)clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies.Autoimmunity,2006,39:233-241.
  • 7Fathi M,Dastmalchi M,Rasmussen E,et al.Interstitial lung disease,a common manifestation of newly diagnosed polymyositis and dermatomyositis.Ann Rheum Dis,2004,63:297-301.
  • 8Gunawardena H,Betteridge ZE,McHugh NJ.Pathogenic mechanisms of disease in myositis:autoantigens as clues.Curr Opin Rheumatol,2009,20:675-680.
  • 9Mielnik P,Wiesik-Szewczyk E,Olesinska M,et al.Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies.Autoimmunity, 2006, 39:243-247.
  • 10Mimori T,Imura Y,Nakashima R,et al.Autoantibodies in idiopathic inflammatory myopathy:an update on clinical and pathophysiological significance.Curr Opin Rheumatol, 2007, 19:523-529.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部